Research  >  About SRI  >  Message From the Vice-President, Research

Message From the Vice-President, Research

Michael Julius

"Discovery to clinical impact through the medical market place” is the mantra that fuels the continual evolution of SRI. A simple concept at first blush, it merits unpacking.

"Discovery" is straightforward. It underpins our ability to invent the future of health care.

The scope of "clinical impact" is broader than perhaps obvious. It highlights our goal to lead in the development and implementation of health care advances that form the foundation of precision medicine, broadly defined as targeted interventions tailored to the person; and image-guided therapeutics. It also captures the world-first innovations we are achieving, as well as the strategic integration of the research and clinical domains of Sunnybrook that make achieving these accomplishments possible.

To highlight just a few examples, we are pioneering a breakthrough technology called focused ultrasound to treat brain disease where there are few or no options; developing imaging tools that can predict which women with breast cancer will respond to chemotherapy; and defining the fundamental role of genes toward developing immunotherapy.

"Through the medical market place" highlights the dozens of private sector partners through which SRI supports the high risk and high cost of technology development and commercialization, in most cases the only way to get our discoveries to our patients.

It would not be hyperbole to say that this conceptual foundation uniquely positions SRI within the constellation of hospital-based research institutes. Our accomplishments exemplify the power of this foundation in enabling us to have paradigm-changing impact on clinical care.

Health care is at the precipice of profound change. Here, the journey is well underway and Sunnybrook’s leadership role, validated internationally, is our legacy.

Michael Julius
Vice-President, Research
Sunnybrook Research Institute & Sunnybrook Health Sciences Centre
Professor, Departments of Immunology & Medical Biophysics
Faculty of Medicine, University of Toronto